Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
Miyazaki Y, Kiguchi T, Sato S, Usuki K, Ishiyama K, Ito Y, Suzuki T, Taguchi J, Chiba S, Dobashi N, Tomita A, Harada H, Handa H, Horiike S, Maeda T, Matsuda M, Ichikawa M, Hata T, Honda S, Iyama S, Suzushima H, Moriuchi Y, Kurokawa T, Yokota K, Ohtake S, Yamauchi T, Matsumura I, Kiyoi H, Naoe T; Japan Adult Leukemia Study Group. Miyazaki Y, et al. Among authors: chiba s. Int J Hematol. 2022 Aug;116(2):228-238. doi: 10.1007/s12185-022-03347-3. Epub 2022 May 4. Int J Hematol. 2022. PMID: 35508695 Clinical Trial.
Comparison of fludarabine-based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry-based study.
Kurita N, Imahashi N, Chiba S, Tanaka M, Kobayashi H, Uchida N, Kuriyama T, Anzai N, Nawa Y, Nakano N, Ara T, Onizuka M, Katsuoka Y, Koi S, Kimura T, Ichinohe T, Atsuta Y, Kanda J; Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Kurita N, et al. Among authors: chiba s. Am J Hematol. 2024 Feb;99(2):236-244. doi: 10.1002/ajh.27172. Epub 2024 Jan 2. Am J Hematol. 2024. PMID: 38165068
[Acute myeloid leukemia harboring NUP98::DDX10].
Kurita N, Kato T, Nanmoku T, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Yokoyama Y, Yoshida C, Tsuboi Y, Obara N, Nishikii H, Sakata-Yanagimoto M, Chiba S. Kurita N, et al. Among authors: chiba s. Rinsho Ketsueki. 2022;63(10):1397-1401. doi: 10.11406/rinketsu.63.1397. Rinsho Ketsueki. 2022. PMID: 36351646 Japanese.
[Hematopoietic recovery by ASXL1-mutated clones after immune suppressive therapy in a patient with severe aplastic anemia].
Shimizu Y, Nishikii H, Iitsuka T, Matsuoka R, Kurita N, Sakamoto T, Yokoyama Y, Kato T, Suehara Y, Hattori K, Maruyama Y, Nannya Y, Ogawa S, Sakata-Yanagimoto M, Chiba S, Obara N. Shimizu Y, et al. Among authors: chiba s. Rinsho Ketsueki. 2023;64(1):49-53. doi: 10.11406/rinketsu.64.49. Rinsho Ketsueki. 2023. PMID: 36775307 Japanese.
[Lymphoplasmacytic lymphoma accompanied by severe myelofibrosis].
Takarada A, Momose H, Kurita N, Matsuoka R, Nakamura N, Sakamoto T, Kato T, Hattori K, Suehara Y, Yokoyama Y, Nishikii H, Maruyama Y, Obara N, Chiba S, Sakata-Yanagimoto M. Takarada A, et al. Among authors: chiba s. Rinsho Ketsueki. 2023;64(1):54-59. doi: 10.11406/rinketsu.64.54. Rinsho Ketsueki. 2023. PMID: 36775308 Japanese.
[Molecular basis of hematological malignancies].
Kitamura T, Inoue D, Nakahara F, Okochi N, Kato N, Togami K, Uchida T, Kagiyama Y, Kawabata KC, Nagase R, Horikawa S, Hayashi K, Saika M, Izawa K, Oki T, Chiba S, Harada Y, Harada H, Kitaura J. Kitamura T, et al. Among authors: chiba s. Rinsho Ketsueki. 2014 Oct;55(10):1715-23. Rinsho Ketsueki. 2014. PMID: 25297732 Review. Japanese. No abstract available.
2,656 results